Validiti · Healthcare on the new substrate

The structural shift

Every clinical interaction today generates records in someone else's system. The records vendor (Epic, Cerner, athenahealth) is structurally the trust broker. The insurer is a third party translating between you and the doctor. Pharma supply chain is a chain-of-custody nightmare. Public health surveillance lags by weeks. Clinical trials are slow because data integrity across sites is a manual process. Every one of these is a substrate workaround.

When signed medical records live on commodity hardware the patient owns, the entity boundary moves from the records vendor to the person. The records vendor becomes a tool the patient uses, not a tool that owns the patient.

The fundamental claim · 2026

That single change reshapes the clinical encounter, the insurance flow, the audit trail, the trial pipeline, the public health response, and the supply chain. None of it requires a new clinical theory. All of it requires the substrate underneath to keep up with the medicine.

The loop, before and after

Today, your medical history is the union of fragments held by everyone who's billed you. Tomorrow, your medical history is one signed record you carry.

Today · custodial

Records fragmented across billing relationships

PCP → specialist → hospital → lab → pharmacy → insurer

Each step generates records in a different system. The patient sees only the slice the provider chooses to release. Continuity of care depends on faxes and PDFs. The full picture exists nowhere — not even with the patient.

With VSS · patient-owned

One signed record you carry across every encounter

patient device ↔ every clinical surface

Every encounter writes to the patient's substrate, signed by the provider. The patient is the canonical source; the providers are the contributors. Anyone the patient authorizes can read; nobody can rewrite. The full picture exists on the patient's hardware.

What changes — nine domains

One pattern, many parts of medicine. In each case, today's bottleneck is the substrate — not the science, not the law, not the will.

01 · Patient records

You own the canonical version

TodayFragmented across every provider's EHR. The "patient portal" shows you a slice; the rest you don't see.

With usYour signed substrate is the canonical record. Providers contribute; you carry it; you grant access.

02 · Insurance claims

Adjudication collapses

TodayProvider bills; insurer adjudicates; denials trigger appeals; patients caught in the middle for months.

With usThe clinical encounter, the coding, and the policy terms are all signed. Adjudication is a math function, not a negotiation.

03 · Clinical trials

Cross-site data integrity is structural

TodayMulti-site trials spend months reconciling data; CRO middle layer; FDA submissions delayed for data-cleaning passes.

With usEvery measurement signed at the moment of collection by the site. Cross-site integrity is mathematical, not procedural.

04 · Pharma supply chain

Counterfeits become operationally impossible

TodayCounterfeit drugs kill an estimated 250K people/year globally. Track-and-trace is mostly paper.

With usEvery dose signed at manufacture, every hop signed in transit, verified at dispense. Counterfeits can't pass verification.

05 · Public health surveillance

Real-time, not weeks-late

TodayDisease surveillance runs on lagging reports. Outbreak detection is days-to-weeks behind.

With usAggregate signals (k-anonymized) flow from clinical surfaces in real time. Outbreak signal arrives hours after the first cases, not weeks.

06 · Prior authorization

The 23-day delay disappears

TodayPrior auth is the #1 source of physician burnout. Median 23-day turnaround. Patients suffer through the wait.

With usPolicy terms + clinical criteria are signed contracts. Authorization is a math function evaluated at the moment of the order.

07 · Care coordination

Hand-offs stop dropping the ball

TodayTransitions of care (hospital→home, specialist→PCP, ER→follow-up) lose information at every hop. Medication errors compound.

With usThe patient's substrate is the canonical source. Every receiving provider reads the same signed record. Nothing falls through the cracks.

08 · Genomics & personal biology

Your biology stays yours

TodaySend a sample to 23andMe or Ancestry; the company owns the data, sells it to researchers, can be acquired by interests adverse to you.

With usSequencing on commodity hardware writes to your substrate. Researchers can request access; you grant or deny; nobody else holds your sequence.

09 · Medical device telemetry

Your pump's data is your data

TodayInsulin pumps, CGMs, pacemakers, CPAPs phone home to the manufacturer. Patient may or may not see it. Manufacturer monetizes.

With usDevice writes to your substrate, signed by the device. You share with your care team on your terms. Manufacturer sees nothing unless you let them.

The deeper shift — who owns the body's record

Two structural failures in modern medicine that are substrate failures, not method failures.

The custodial assumption, broken

For 50 years US healthcare has assumed that records belong to the entity that created them. HIPAA gives you the right to see your records; it doesn't give you the records. The records still live with the custodian, who decides format, retention, release.

When the patient is the canonical source, the custodial assumption inverts. Providers contribute to a record they don't own. The patient is the platform; the providers are the apps. That single inversion deletes an entire industry's worth of friction.

The intermediary, priced out

Insurance is structurally a translator: it sits between the patient and the provider because neither can trust the other directly with payment. The translator extracts roughly 18% of every healthcare dollar in the US for the service of mediating that distrust.

When the substrate carries signed contracts and signed clinical encounters bilaterally, the translator becomes optional. Insurance doesn't disappear — risk-pooling still has economic value — but the operational friction (claims, denials, prior auth, recoupments, appeals) collapses into substrate-level math. That 18% gets returned to the people doing the medicine.

And it runs on a $30 device

The price-point matters more in healthcare than almost anywhere else, because the population most underserved by current systems is the population with the least capital to spend on intermediation.

A patient in a rural clinic in Mississippi with a $30 device has the same medical-record substrate a patient at Massachusetts General has.

Rural hospitals are closing because they can't afford the EHR vendor licenses. Free clinics serve millions of patients on systems that don't talk to anyone else's systems. Undocumented immigrants accumulate decades of medical history that nobody can find when they show up in an ER. The substrate at commodity-hardware price points fixes all three. Not by funding the existing intermediary system better; by making the intermediary optional for the populations who can't afford it in the first place.

This is the most progressive thing a piece of infrastructure has done in a generation, and it doesn't require a single policy change to deliver.

When your medical history lives on your hardware, the system bends to the patient.